Lateral Epicondylalgia: The Tendon Loading Revolution That Changed Everything

Lateral epicondylalgia — the condition most clinicians and patients still call tennis elbow — has undergone a conceptual revolution in the past 20 years. The recognition that chronic lateral epicondylalgia is not a primarily inflammatory condition, but rather a failed healing response characterised by disorganised collagen and neurovascular ingrowth without the classic inflammatory cells, has transformed how we think about it, investigate it, and treat it. This is one of the most clear-cut examples in musculoskeletal medicine of how basic science evidence can directly transform clinical practice for the better.

What this means for treatment

If the pathology is failed tendon healing rather than active inflammation, the treatment imperative becomes stimulating a healing response rather than suppressing inflammation. This is the biological rationale for high-load progressive tendon rehabilitation: systematic eccentric and concentric loading of the common extensor origin, progressed over 8–12 weeks, stimulates collagen synthesis, promotes tendon reorganisation, and produces the structural adaptation that explains the lasting improvements observed in well-conducted trials.

The programme is demanding. Patients experience pain during the loading exercises — not despite doing them correctly, but because they are doing them correctly. Teaching patients that provoked pain during loading is acceptable, expected, and biologically productive is one of the most important elements of the educational component of treatment. The pain monitoring model — using a numerical rating scale to keep exercise pain in the acceptable range — gives patients a tool for managing this process safely.

Putting the kinetic chain back in focus

The most innovative shift in lateral epicondylalgia management over recent years is the systematic incorporation of kinetic chain assessment. The forearm extensors do not load themselves in isolation. Shoulder stabiliser weakness, scapular control deficits, and reduced posterior chain stiffness all increase the compressive and tensile forces transmitted to the common extensor origin during upper limb activities. A rehabilitation programme that addresses only the elbow is addressing the symptom. One that rehabilitates the chain is addressing the system.

For patients who remain symptomatic after a full, well-structured programme of progressive loading — typically 3–4 months of consistent effort — platelet-rich plasma injection offers a biologically rational adjunct. The evidence at two years supports its use in chronic, refractory cases, and the patient's understanding of how it works — not as a cure in itself but as a facilitator of healing that requires continued loading — is essential for appropriate expectation management.